Testing and treatment for H. pylori to prevent stomach cancer death
Part of Cancer, Digestive system clinical trials.
This trial studies whether testing for an infection called H. pylori and using simple blood/screening tests (pepsinogen testing) can help prevent stomach cancer and reduce stomach-cancer-related deaths. You would be followed for health outcomes to see if the approach works better than standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 40 and 64 years old when you sign consent
- You’re willing to join and accept any study assignment after you understand the risks and benefits
- You can sign a consent form, including permission to move samples across borders if needed
- Your doctor must judge that you’re in “good health” based on exam and medical history
- You do NOT have a past history of stomach (gastric) cancer
- You have not had H. pylori eradication treatment within the last 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests and treats young adults for H. pylori, a stomach bacteria, to see if treating it reduces future health risks. If you haven't been treated for H. pylori before, you may join.
This study looks for early signs of stomach cancer and Barrett's esophagus (a precancerous condition) in people who are already getting a routine colonoscopy. By adding a quick upper endoscopy during the same visit, doctors can check for H. pylori infection and abnormal tissue changes without extra hassle.
This study follows adults with past or current H. pylori infection to better understand stomach lining changes such as atrophic gastritis and intestinal metaplasia, and to monitor for possible progression. It may help by improving how doctors track risk over time and use stored tissue samples to learn more.
This trial tests whether treating a specific high-risk type of H. pylori (a stomach bacteria) can lower the chance of stomach cancer. If you carry this type, you may be able to join a study group that gets treatment and is followed over time.
This study follows people who carry a high-risk type of Helicobacter pylori (a stomach bacteria) to see if they develop gastric cancer. It aims to understand who is most at risk and how to monitor them over time.
This study looks at a screening plan to prevent stomach cancer by identifying people who should be tested and treated for H. pylori, a common stomach germ. If you have never had H. pylori testing or treatment, the trial may help determine the best approach for prevention.
Hear when a new Atrophic Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.